Director, Clinical Operations,
Global Blood Therapeutics (PFIZER)
Noel Landsman is Director Clinical Operations for the Inclacumab THRIVE studies at Global Blood Therapeutics (Pfizer). He is an experienced operational lead with a strong foundation in Clinical Operations, Clinical Risk Management, Data Protection and Clinical Project Management. His experience has been gained working within the CRO, Charity and Biopharm environment. Prior to joining GBT, he enjoyed a 17year career at Quintiles (IQVIA) within Project Management and Business Operations. He is experienced within operations with knowledge of clinical trials at various stages of development (i.e. Phase I to Phase IV: Global registry studies Haematology) with international experience in overseeing projects at sites across global regions.